Intracranial stents market seen reaching $1.13 billion by 2030

The intracranial stents market is projected to grow from $0.54 billion in 2025 to $1.13 billion by 2030, driven by rising aneurysm cases, broader use of minimally invasive neurointerventions and newer stent technologies. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Intracranial stents are used to treat brain vessel narrowing and aneurysms, which can reduce the risk of stroke or hemorrhage. - The market’s projected 15.6% CAGR through 2030 points to sustained demand for neurovascular treatment tools as cerebrovascular disease burden rises.

What happened: - The intracranial stents market was valued at $0.54 billion in 2025. - The market is forecast to reach $0.63 billion in 2026, implying 16.1% growth year over year. - The market is projected to climb to $1.13 billion by 2030. - The forecast period reflects a 15.6% compound annual growth rate. - The Business Research Company released the market outlook on August 13, 2026. - A free sample report is available. - A full market report is also available.

The details: - Intracranial stents are tubular devices implanted in blood vessels or ducts in the brain. - The devices are used for intracranial stenosis and brain aneurysms by opening blocked arteries and restoring blood flow. - The market’s growth drivers include a rising number of intracranial aneurysm cases. - The market is also benefiting from higher prevalence of cerebrovascular disorders. - Advancements in endovascular therapies are expanding treatment options. - More neurology specialty centers are supporting broader access to care. - Wider acceptance of minimally invasive neurointerventions is helping adoption. - Key trends include neurovascular stenting, stent-assisted coil embolization, biodegradable stents and neuroimaging-guided procedures. - The market is also being shaped by stronger focus on stroke and aneurysm management. - Brain Aneurysm Foundation data from August 2023 showed about 6.7 million people in the United States, or roughly 1 in 50, live with an unruptured brain aneurysm. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing regional market during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests market expansion is being driven less by one breakthrough and more by multiple overlapping clinical and technology trends. - The emphasis on minimally invasive treatment reflects a broader shift in neurovascular care toward procedures that can improve outcomes while reducing recovery time. - The regional split suggests mature markets will likely stay revenue leaders, while faster growth may come from regions that are still expanding specialty care capacity.

What's next: - Growth will likely track continued adoption of next-generation stents and neuroimaging-guided procedures. - Investment in neurovascular research and early stroke intervention could further support uptake. - The report notes updated 2026 features including market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards and market hotspot infographics. - The Business Research Company listed Saumya Sahay as a contact for expert inquiries.